Yahoo! Finance: SPPI News

7 Stocks on a Roll (at Motley Fool)

Mon, 28 Dec 2009 14:46:31 Etc/GMT

5 Stocks Bouncing Back (at Motley Fool)

Fri, 11 Dec 2009 18:44:00 Etc/GMT

Zevalin® (Ibritumomab Tiuxetan) Demonstrated Activity in Several Investigational Phase 2 Trials Presented at the 51st Annual Meeting of the American Society of Hematology (Business Wire)

Fri, 11 Dec 2009 12:00:00 Etc/GMT

IRVINE, Calif.----Spectrum Pharmaceuticals, Inc. , a commercial stage biotechnology company with a primary focus in oncology, today announced that clinical data on ZEVALIN was presented at the 51st Annual Meeting of the American Society of Hematology , which was held December 5-8, 2009 at the Ernest N.

Key Stocks Do Better Under New Health Care Legislation Pending In Congress States Lazard Capital Award Winning Equity Analyst (Wall Street Transcript)

Wed, 9 Dec 2009 13:48:00 Etc/GMT

67 WALL STREET, New York - December 9, 2009 - The Wall Street Transcript has just published its Consumer Health Services Report offering a timely review of the sector to serious investors and industry executives. This 53 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Spectrum Pharmaceuticals Ranked among Orange County's Top Work Places for 2009 (Business Wire)

Wed, 9 Dec 2009 12:00:00 Etc/GMT

IRVINE, Calif.----Spectrum Pharmaceuticals , a commercial stage biotechnology company with a primary focus in oncology, today announced that it has been ranked by the Orange County Register as one of Orange County’s Top Work Places for 2009.

Prospecting for Stocks: DepoMed (at Motley Fool)

Tue, 8 Dec 2009 15:11:06 Etc/GMT

SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements (EDGAR Online)

Tue, 8 Dec 2009 12:30:38 Etc/GMT

Spectrum Pharmaceuticals Engages Ernst & Young LLP as New Independent Registered Public Accounting Firm (Business Wire)

Tue, 8 Dec 2009 12:00:00 Etc/GMT

IRVINE, Calif.----Spectrum Pharmaceuticals today announced that the Audit Committee of the Board of Directors of the Company approved the engagement of Ernst & Young, LLP as the Company’s new independent registered public accounting firm.

Generic Drugs Continue To Accelerate Market Share Expansion According To Sanford Bernstein (Wall Street Transcript)

Mon, 7 Dec 2009 13:18:00 Etc/GMT

67 WALL STREET, New York - December 7, 2009 - The Wall Street Transcript has just published its Consumer Health Services Report offering a timely review of the sector to serious investors and industry executives. This special feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Stocks Doing Right by Shareholders (at Motley Fool)

Fri, 4 Dec 2009 17:17:17 Etc/GMT

December's Defensive Game Plan for Biotech (at Seeking Alpha)

Tue, 1 Dec 2009 15:06:07 Etc/GMT

Spectrum Pharmaceuticals Announces ZEVALIN® Data Presentations at the 51st Annual Meeting of the American Society of Hematology in New Orleans (Business Wire)

Tue, 1 Dec 2009 12:00:00 Etc/GMT

IRVINE, Calif.----Spectrum Pharmaceuticals, Inc. , a commercial stage biotechnology company with a primary focus in oncology, today announced that clinical data on ZEVALIN will be presented at the 51st Annual Meeting of the American Society of Hematology , being held December 5-8, 2009 at the Ernest N.

Spectrum Pharmaceuticals Announces Completion of Enrollment in One Apaziquone Phase 3 Pivotal Trial for Bladder Cancer Ahead of Schedule (Business Wire)

Mon, 30 Nov 2009 12:00:00 Etc/GMT

IRVINE, Calif.----Spectrum Pharmaceuticals today announced that one of the two Phase 3 pivotal clinical trials of apaziquone has achieved its enrollment target, having enrolled approximately 800 patients with non-invasive bladder cancer.

Biotech Bargains for Your Portfolio (at Motley Fool)

Fri, 27 Nov 2009 15:58:57 Etc/GMT

2 Stocks Hitting High Notes (at Motley Fool)

Wed, 25 Nov 2009 19:48:28 Etc/GMT

A Big Upgrade for Allos Therapeutics (at Motley Fool)

Mon, 23 Nov 2009 14:16:27 Etc/GMT

iBasis, Tower Semi: Early Volume Plays (at TheStreet.com)

Mon, 23 Nov 2009 13:53:21 Etc/GMT

Spectrum Pharmaceuticals and Handok Pharmaceuticals Announce Collaboration Agreement for Apaziquone in South Korea (Business Wire)

Mon, 23 Nov 2009 12:00:00 Etc/GMT

IRVINE, Calif.----Spectrum Pharmaceuticals, Inc. , a commercial stage biotechnology company with a primary focus in oncology, and Handok Pharmaceuticals Co., Ltd., a fully integrated Korean pharmaceutical company, today announced a collaboration for the development and commercialization of apaziquone in South Korea.

Spectrum Pharma: Zevalin Sales Ramp Up (at Seeking Alpha)

Sun, 22 Nov 2009 13:32:12 Etc/GMT

SPECTRUM PHARMACEUTICALS INC Financials (EDGAR Online Financials)

Tue, 17 Nov 2009 14:04:36 Etc/GMT